Notably, the most highlighted cellular process hypothesized to be disrupted in C9-ALS/FTLD and linked to these gain-of-function mechanisms is the nucleocytoplasmic (nuc/cyto) transport pathway39,60–66. This evidence concerns the gene C9 and amyotrophic lateral sclerosis.